Literature DB >> 26323873

Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid.

Federica Vannini1, Andrew C MacKessack-Leitch2, Erin K Eschbach1, Mitali Chattopadhyay1, Ravinder Kodela1, Khosrow Kashfi3.   

Abstract

We recently reported the synthesis of NOSH-aspirin, a novel hybrid compound capable of releasing both nitric oxide (NO) and hydrogen sulfide (H2S). In NOSH-aspirin, the two moieties that release NO and H2S are covalently linked at the 1, 2 positions of acetyl salicylic acid, i.e., ortho-NOSH-aspirin. Here we report on the synthesis of meta- and para-NOSH-aspirins. We also made a head-to-head evaluation of the effects of these three positional isomers of NOSH-aspirin on colon cancer cell kinetics and induction of reactive oxygen species, which in recent years has emerged as a key event in causing cancer cell regression. Electron donating/withdrawing groups incorporated about the benzoate moiety significantly affected the potency of these compounds with respect to colon cancer cell growth inhibition.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell kinetics; Colon cancer; Hydrogen sulfide; NOSH-aspirin; Nitric oxide; Reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26323873      PMCID: PMC4592841          DOI: 10.1016/j.bmcl.2015.08.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.

Authors:  Mitali Chattopadhyay; Ravinder Kodela; Kenneth R Olson; Khosrow Kashfi
Journal:  Biochem Biophys Res Commun       Date:  2012-02-16       Impact factor: 3.575

2.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

3.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Authors:  Robert S Sandler; Susan Halabi; John A Baron; Susan Budinger; Electra Paskett; Roger Keresztes; Nicholas Petrelli; J Marc Pipas; Daniel D Karp; Charles L Loprinzi; Gideon Steinbach; Richard Schilsky
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

Review 4.  Hydrogen sulfide and nitric oxide interactions in inflammation.

Authors:  Maria Letizia Lo Faro; Bridget Fox; Jacqueline L Whatmore; Paul G Winyard; Matthew Whiteman
Journal:  Nitric Oxide       Date:  2014-06-11       Impact factor: 4.427

Review 5.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

6.  NOSH-Aspirin: A Novel Nitric Oxide-Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals.

Authors:  Ravinder Kodela; Mitali Chattopadhyay; Khosrow Kashfi
Journal:  ACS Med Chem Lett       Date:  2012-01-28       Impact factor: 4.345

7.  Requirement for generation of H2O2 for platelet-derived growth factor signal transduction.

Authors:  M Sundaresan; Z X Yu; V J Ferrans; K Irani; T Finkel
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

8.  Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential.

Authors:  Ravinder Kodela; Mitali Chattopadhyay; Khosrow Kashfi
Journal:  Medchemcomm       Date:  2013       Impact factor: 3.597

9.  Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

Authors:  Peter M Rothwell; Michelle Wilson; Jacqueline F Price; Jill F F Belch; Tom W Meade; Ziyah Mehta
Journal:  Lancet       Date:  2012-03-21       Impact factor: 79.321

10.  Selective fluorescent imaging of superoxide in vivo using ethidium-based probes.

Authors:  Kristine M Robinson; Michael S Janes; Mariana Pehar; Jeffrey S Monette; Meredith F Ross; Tory M Hagen; Michael P Murphy; Joseph S Beckman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

View more
  8 in total

Review 1.  Chemical Biology of H2S Signaling through Persulfidation.

Authors:  Milos R Filipovic; Jasmina Zivanovic; Beatriz Alvarez; Ruma Banerjee
Journal:  Chem Rev       Date:  2017-11-07       Impact factor: 60.622

Review 2.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

3.  Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.

Authors:  Federica Vannini; Mitali Chattopadhyay; Ravinder Kodela; Praveen P N Rao; Khosrow Kashfi
Journal:  Redox Biol       Date:  2015-08-20       Impact factor: 11.799

4.  Synthesis of aspirin-curcumin mimic conjugates of potential antitumor and anti-SARS-CoV-2 properties.

Authors:  Aladdin M Srour; Siva S Panda; Ahmed Mostafa; Walid Fayad; May A El-Manawaty; Ahmed A F Soliman; Yassmin Moatasim; Ahmed El Taweel; Mohamed F Abdelhameed; Mohamed S Bekheit; Mohamed A Ali; Adel S Girgis
Journal:  Bioorg Chem       Date:  2021-11-04       Impact factor: 5.275

Review 5.  Anticancer and Anti-Inflammatory Mechanisms of NOSH-Aspirin and Its Biological Effects.

Authors:  Jun Zhou; Weihong Zeng; Ying Zeng; Yukun Li; Zheng Xiao; Juan Zou; Lijun Peng; Jiliang Xia; Xi Zeng
Journal:  Comput Math Methods Med       Date:  2022-08-17       Impact factor: 2.809

6.  Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate.

Authors:  Laiyin Zhang; Shuangxing Hou; Bo Li; Jianjian Pan; Liping Jiang; Guiying Zhou; Hong Gu; Caixing Zhao; Huiping Lu; Fenfen Ma
Journal:  Onco Targets Ther       Date:  2018-01-15       Impact factor: 4.147

Review 7.  Recent Development of Hydrogen Sulfide Releasing/Stimulating Reagents and Their Potential Applications in Cancer and Glycometabolic Disorders.

Authors:  Chun-Tao Yang; Li Chen; Shi Xu; Jacob J Day; Xiang Li; Ming Xian
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

8.  Greener Synthesis of Antiproliferative Furoxans via Multicomponent Reactions.

Authors:  Mariana Ingold; Victoria de la Sovera; Rosina Dapueto; Paola Hernández; Williams Porcal; Gloria V López
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.